Synhumanisation®
Synhumanisation® is Arana’s second proprietary technology, which uses a novel method of re-combining antibody sequences to convert antibodies of non-human origin to antibodies suitable for use in humans.An important advantage of Arana’s Synhumanisation® technology is that for some existing, validated targets it opens up an approach to generate patentable new antibody products that would otherwise be excluded by conventional ‘humanisation’, or fully human antibody approaches due to existing competitor patents.
